Virus Diseases Completed Phase 3 Trials for Meningococcal polysaccharide vaccine group C (DB13890)

Also known as: Virus Disease

IndicationStatusPhase
DBCOND0028162 (Virus Diseases)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01553279Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011)Prevention
NCT01839188Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010)Prevention
NCT01839175Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster VaccinationPrevention